Dr. Ralph Kern, Chief Medical Officer, BrainStorm Cell Therapeutics talks about their late stage clinical programs in treating ALS and MS using stem cells derived from bone marrow as well as the promise of using their technology platform to manufacture the cells to develop therapies for other neurodegenerative diseases like Parkinson's and Huntington's Disease and autism. While not a cure, this therapy using repair molecules is focused on stabilizing and preventing further deterioration.
#BrainStormALS
#BCLI #ALS #EndALS
BrainStorm Cell Therapeutics
Download the transcript here
Empowered Patient Podcast